CRBP - Corbus Pharmaceuticals files for $300M mixed shelf offering
2024-03-13 17:18:18 ET
More on Corbus Pharmaceuticals
- Corbus: Ability To Have Best-In-Class Nectin-4 Targeting Drug
- Corbus Pharmaceuticals: Surging On The Back Of Great News, But I See Dark Clouds
- Corbus Pharmaceuticals announces proposed public offering of common stock
- Corbus Pharma reverses gains on common stock offering
- Seeking Alpha’s Quant Rating on Corbus Pharmaceuticals